BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2918325)

  • 1. Survival in multiple sclerosis.
    Poser S; Kurtzke JF; Poser W; Schlaf G
    J Clin Epidemiol; 1989; 42(2):159-68. PubMed ID: 2918325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival pattern and cause of death in patients with multiple sclerosis: results from an epidemiological survey in north east Scotland.
    Phadke JG
    J Neurol Neurosurg Psychiatry; 1987 May; 50(5):523-31. PubMed ID: 3495637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic factors for life expectancy in multiple sclerosis analysed by Cox-models.
    Riise T; Grønning M; Aarli JA; Nyland H; Larsen JP; Edland A
    J Clin Epidemiol; 1988; 41(10):1031-6. PubMed ID: 3193137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic indicators in multiple sclerosis.
    Poser S; Poser W; Schlaf G; Firnhaber W; Lauer K; Wolter M; Evers P
    Acta Neurol Scand; 1986 Nov; 74(5):387-92. PubMed ID: 3825497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Excess Mortality in Patients with Multiple Sclerosis Starts at 20 Years from Clinical Onset: Data from a Large-Scale French Observational Study.
    Leray E; Vukusic S; Debouverie M; Clanet M; Brochet B; de Sèze J; Zéphir H; Defer G; Lebrun-Frenay C; Moreau T; Clavelou P; Pelletier J; Berger E; Cabre P; Camdessanché JP; Kalson-Ray S; Confavreux C; Edan G
    PLoS One; 2015; 10(7):e0132033. PubMed ID: 26148099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival and cause of death in multiple sclerosis: a 60-year longitudinal population study.
    Lunde HMB; Assmus J; Myhr KM; Bø L; Grytten N
    J Neurol Neurosurg Psychiatry; 2017 Aug; 88(8):621-625. PubMed ID: 28365589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The natural history of multiple sclerosis: a geographically based study. 5. The clinical features and natural history of primary progressive multiple sclerosis.
    Cottrell DA; Kremenchutzky M; Rice GP; Koopman WJ; Hader W; Baskerville J; Ebers GC
    Brain; 1999 Apr; 122 ( Pt 4)():625-39. PubMed ID: 10219776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival of patients with multiple sclerosis in Denmark: a nationwide, long-term epidemiologic survey.
    Brønnum-Hansen H; Koch-Henriksen N; Hyllested K
    Neurology; 1994 Oct; 44(10):1901-7. PubMed ID: 7936244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relative mortality and survival in multiple sclerosis: findings from British Columbia, Canada.
    Kingwell E; van der Kop M; Zhao Y; Shirani A; Zhu F; Oger J; Tremlett H
    J Neurol Neurosurg Psychiatry; 2012 Jan; 83(1):61-6. PubMed ID: 21865212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prognosis and life expectancy in multiple sclerosis].
    Angstwurm H
    Versicherungsmedizin; 1991 Apr; 43(2):52-4. PubMed ID: 2058080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term survival experience of patients with multiple sclerosis.
    Pokorski RJ
    J Insur Med; 1997; 29(2):101-6. PubMed ID: 10169627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the natural history and prognostic features of early onset and adult onset multiple sclerosis in Jordanian population.
    El-Salem K; Khader Y
    Clin Neurol Neurosurg; 2007 Jan; 109(1):32-7. PubMed ID: 16870328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The natural history of multiple sclerosis: a regional study with some longitudinal data.
    Miller DH; Hornabrook RW; Purdie G
    J Neurol Neurosurg Psychiatry; 1992 May; 55(5):341-6. PubMed ID: 1602305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival and predictors of disability in Turkish MS patients. Turkish Multiple Sclerosis Study Group (TUMSSG).
    Kantarci O; Siva A; Eraksoy M; Karabudak R; Sütlaş N; Ağaoğlu J; Turan F; Ozmenoğlu M; Toğrul E; Demirkiran M
    Neurology; 1998 Sep; 51(3):765-72. PubMed ID: 9748024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival of multiple sclerosis in Finland between 1964 and 1993.
    Sumelahti ML; Tienari PJ; Wikström J; Salminen TM; Hakama M
    Mult Scler; 2002 Aug; 8(4):350-5. PubMed ID: 12166507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparative epidemiologic analysis of multiple sclerosis in areas of Central and Southern Europe].
    Buddenhagen F; Pantović MM
    Psychiatr Neurol Med Psychol (Leipz); 1985 Oct; 37(10):565-72. PubMed ID: 3878969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Multiple sclerosis mortality in Poland].
    Cendrowski W
    Neurol Neurochir Pol; 1986; 20(5):444-7. PubMed ID: 3587514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple sclerosis survival: a population-based study in Sicily.
    Ragonese P; Aridon P; Mazzola MA; Callari G; Palmeri B; Famoso G; Terruso V; Salemi G; D'Amelio M; Savettieri G
    Eur J Neurol; 2010 Mar; 17(3):391-7. PubMed ID: 19863646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A representative cohort of patients with non-progressive multiple sclerosis at the age of normal life expectancy.
    Skoog B; Runmarker B; Winblad S; Ekholm S; Andersen O
    Brain; 2012 Mar; 135(Pt 3):900-11. PubMed ID: 22366800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Multiple sclerosis as mortality diagnosis in the Federal Republic of Germany (author's transl)].
    Resch J
    Fortschr Neurol Psychiatr; 1982 Feb; 50(2):52-63. PubMed ID: 7095715
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.